Literature DB >> 25145922

Selective Embolization of Systemic Collaterals for the Treatment of Recurrent Hemoptysis Secondary to the Unilateral Absence of a Pulmonary Artery in a Child.

Yin Zhou1, Jiaywei Tsauo2, Yuan Li3, Xiao Li4.   

Abstract

The unilateral absence of the pulmonary artery (UAPA) is a rare anomaly. Hemoptysis due to systemic collaterals is one of the most common complications of UAPA. To the best of the authors' knowledge, the utility of selective embolization for the treatment of this condition in children has not been reported previously. This report describes a 6-year-old girl with isolated UAPA (IUAPA) admitted for a 10-month history of recurrent hemoptysis that had worsened during the previous 2 months. Selective embolization of the bronchial systemic collaterals was performed. The patient remained asymptomatic with no recurrence of hemoptysis 8 months after the procedure.

Entities:  

Keywords:  Pulmonary atresia; Transcatheter arterial embolization

Mesh:

Year:  2014        PMID: 25145922     DOI: 10.1007/s00270-014-0965-3

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  Unilateral Absence of the Left Pulmonary Artery With an Associated Vascular Anomaly in Adulthood.

Authors:  Miguel Flores; Haley Letter; Edward Derrick; Ibrahim Koury
Journal:  Cureus       Date:  2016-03-10

2.  Isolated absence of right pulmonary artery in a 4-year old child: a case report.

Authors:  Abate Yeshidinber Weldetsadik; Yemisrach Mekonnen Asfaw; Atnafu Mekonnen Tekleab
Journal:  Int Med Case Rep J       Date:  2018-10-30

3.  Pediatric Pulmonary Hemorrhage vs. Extrapulmonary Bleeding in the Differential Diagnosis of Hemoptysis.

Authors:  Michael Vaiman; Baruch Klin; Noa Rosenfeld; Ibrahim Abu-Kishk
Journal:  Cent Asian J Glob Health       Date:  2017-10-23

4.  Unilateral pulmonary artery agenesis: An unusual cause of unilateral ARDS.

Authors:  Lakshmi Saladi; Swati Roy; Gilda Diaz-Fuentes
Journal:  Respir Med Case Rep       Date:  2018-02-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.